Eton Pharmaceuticals, Inc. (ETON) Free cash flow 2018–2025
Eton Pharmaceuticals, Inc. (ETON) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$10.2MFY2025 · since FY2018: -$8.4M → $10.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.2M | +980.7% |
| FY2024 | $943,000 | -86.2% |
| FY2023 | $6.8M | +42.5% |
| FY2022 | $4.8M | +201.1% |
| FY2021 | -$4.7M | +78.9% |
| FY2020 | -$22.4M | -17.1% |
| FY2019 | -$19.1M | -128.2% |
| FY2018 | -$8.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ETON financial trends
ETON RevenueETON Net incomeETON Net marginETON Gross profitETON Gross marginETON Operating incomeETON Operating marginETON Operating cash flowETON Capital expendituresETON Return on equityETON Stock buybacksETON Dividends paidETON Total assetsETON Total liabilitiesETON Shareholders’ equityETON overview →